GPER1 and multiple sclerosis: Studies have shown that the anti-inflammatory effect of estrogen is strongly dependent on the GPER, and the GPER-specific agonist G1 has the same significant therapeutic effects as estrogen in multiple sclerosis (Blasko et al., 2009).